# Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts

> **NCT04290572** · PHASE3 · UNKNOWN · sponsor: **Centro Dermatológico Dr. Ladislao de la Pascua** · enrollment: 162 (estimated)

## Conditions studied

- Flat Wart

## Interventions

- **DRUG:** Isotretinoin capsules

## Key facts

- **NCT ID:** NCT04290572
- **Lead sponsor:** Centro Dermatológico Dr. Ladislao de la Pascua
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-15
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-12-31
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290572, "Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04290572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*